Biotech Growth Dividends - BIOG

Biotech Growth Dividends - BIOG

Best deals to access real time data!
Level 2 Basic
Monthly Subscription
for only
Monthly Subscription
for only
UK/US Silver
Monthly Subscription
for only
VAT not included
Stock Name Stock Symbol Market Stock Type Stock ISIN Stock Description
Biotech Growth Trust (the) Plc BIOG London Ordinary Share GB0000385517 ORD 25P
  Price Change Price Change % Stock Price Last Trade
-48.00 -3.39% 1,366.00 16:35:21
Open Price Low Price High Price Close Price Previous Close
1,410.00 1,374.00 1,410.00 1,366.00 1,414.00
more quote information »
Industry Sector

Biotech Growth BIOG Dividends History

Announcement Date Type Currency Dividend Amount Period Start Period End Ex Date Record Date Payment Date Total Dividend Amount

Top Dividend Posts

steeplejack: 2.5% of BIOG portfolio represented by Biogen which jumped some 40% in the US yesterday following FDA approval of its Alzheimer drug.
cliff007: Ali. That's what I meant. I'm wondering what's going on. Another Investment Trust I have WWH, has suffered the same fate so I don't believe it's BIOG specific. I'm holding on.....
healthtech: That's because IBT has a dividend yield of 4% and has outperformed its index. Seems like YTD BIOG is performing better, but need to sustain this to improve its long term performance.
rogerrail: IBT on slight premium to NAV whereas BIOG at a discount . Very similar funds, I would expect BIOG to catch up at some point
andyj: By the way, there is an excellent and insightful free research paper on BIOG at Edison Investment Research dated Feb 22. Sorry I cannot post the link.
andyj: Thanks all, probably sound advice, just having a clear out of underperforming investments in my portfolio and noticed BIOG has consistently been a losing investment for me.
earthmanian: Now it's 10% discount to nav. Biog should now be buying their own shares back, let's see.....
iomhere: BIOG was outperforming over the usual 1 yr and 5 yr yardsticks but has underperformed in a similar fashion recently. As was indicated by urgentclick it's a question of committing oneself when sentiment in the far east and emerging markets quieten down. I'm waiting a bit longer for this to happen and then, hopefully, to see the turn before I further invest.
philo124: Usually very little or no discount to NAV. They, the company, usually buy back their own shares when it exceeds 8% from memory. I also think, unlike Tech funds, that China is not a factor. I have bought BIOG IMT and Allianz Insurance today.
affemoose: Ooops, meant the post the below in case you do not know already. Sorry about above rant!! Geoffrey Hsu of OrbiMed Capital LLC, the Portfolio Manager of The Biotech Growth Trust PLC, will be presenting to investors and shareholders in London on Wednesday, 8 July 2015. BIOG has performed exceptionally well over a sustained period, significantly outperforming both the FTSE All-Share benchmark and the NASDAQ Biotechnology Index over 1, 3 and 5 years. OrbiMed is the world's largest specialist healthcare fund manager with over $15bn invested worldwide. Geoffrey Hsu will provide an update on the biotech sector and the factors determining future growth. The presentation will start soon after 12.15pm, immediately after the conclusion of the ordinary business of the AGM, which commences at 12 noon. More information on The Biotech Growth Trust PLC can be found at Details are as follows: BIOG AGM and Investor Presentation: Date: Wednesday 8th July Time: 12 noon – AGM 12:15 – Investor Presentation 13:30 – Buffet Lunch Venue: Barber Surgeons' Hall, Monkwell Square, London EC2Y 5BD Please RSVP to if you are able to join us, as places are limited.
ADVFN Advertorial
Your Recent History
Biotech Gr..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210613 13:53:38